SynergyMed Devices

Non-surgical Cancer Treatment Technology

Request Veterinary Quote Explore Technology

Veterinary oncology device

Thermal ablation

Smart algorithms

Magnetic nanoparticles

OSU

Ohio State University collaboration

Patented

patented in USA and Europe

Ready

veterinary device sales conversations

SynergyMed Medical Device for Tumor Ablation

Tumor ... Ablated !

Targeting cancer tumors more precisely and effectively, eliminating damage to surrounding healthy tissue

Non-Invasive Thermal Ablation Technology

The non-surgical solution of SynergyMed will serve an unmet need as a replacement or adjuvant treatment for solid superficial tumors.

Innovative Technology

Cutting-edge solutions powered by advanced science and engineering

Unique Algorithms

Smart Proprietary algorithms control the treatment process for improved power efficiency and optimal results

Nano Synergy

Technology combines the use of electromagnetic energy sources with FDA-approved nanoparticles

Precision Targeting

Unique electromagnetic applicators designed to selectively and precisely treat tumors without damaging the healthy tissue

AI-Powered Prediction

Adaptive treatment algorithms that predict treatment outcomes

Transforming cancer treatment

One platform. Two paths forward.

SynergyMed is advancing precise, non-invasive treatment for superficial solid tumors across human and veterinary oncology. Choose the pathway most relevant to your work.

Human oncologyHuman oncologyIn R&DIn development

SynergyMed device platform for human oncology research

Human device

Explore the research, clinical-development, and partnership pathway for human oncology.

Explore human pathway

Vet oncologyVeterinary oncologyFor saleReady for sale

Veterinary device

Review clinical applications, device components, evidence, and purchasing options.

Explore veterinary pathway

Shared technology foundation

Controlled energy
Precision targeting
Smart algorithms

Technology, Applications, and Search Topics

SynergyMed is building a strong non-surgical oncology platform around thermal ablation, magnetic nanoparticles, microwave ablation, radio frequency ablation, and hyperthermia for both human oncology and veterinary oncology use cases.

Thermal Ablation and Smart AlgorithmsExplore Technology

Explore how SynergyMed combines thermal ablation, magnetic nanoparticles, smart algorithms, and controlled electromagnetic energy to support precise oncology workflows.

Explore Technology

Human Oncology Focus AreasView Human Page

See how the platform is being developed for breast cancer, superficial tumors, skin cancer, head and neck cancer, thyroid tumors, brain tumors, and palliative care use cases.

View Human Page

Veterinary Oncology ApplicationsView Veterinary Page

Review veterinary oncology opportunities across mast cell tumors, mammary tumors, carcinoma, soft tissue sarcoma, and other superficial solid tumors in companion animals.

View Veterinary Page

Order, Partnership, and Market AccessGo to Order

Connect with SynergyMed for device orders, research collaboration, investor conversations, and commercialization opportunities in the human cancer market and veterinary cancer market.

Go to Order

Non-Surgical Oncology FAQ

These questions align the homepage with the core technology, clinical intent, and market topics people are already searching for.

What kind of cancer treatment technology does SynergyMed develop?

SynergyMed develops non-surgical cancer treatment technology focused on thermal ablation, controlled electromagnetic energy, magnetic nanoparticles, and smart algorithms for oncology applications.

Does SynergyMed support both human oncology and veterinary oncology?

Yes. The platform is positioned for both human oncology and veterinary oncology, with dedicated pages describing the human device pathway and the veterinary device pathway.

Which search topics are most relevant to the platform?

Key topics include thermal ablation, microwave ablation, radio frequency ablation, hyperthermia, breast cancer, superficial tumors, mast cell tumors, mammary tumors, soft tissue sarcoma, and other non-surgical oncology needs.

Where should partners or buyers start?

Prospective partners, researchers, clinicians, and buyers should review the technology, human, veterinary, order, and contact pages to find the most relevant next step.

Global recognition